RWD98 Understanding the Role of Real-World Evidence for Reimbursement and Market Access of Ultra Orphan Drugs: Insights and Lessons from Case Studies of NICE Highly Specialized Technology (HST) Assessment Reports
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.2127
https://www.valueinhealthjournal.com/article/S1098-3015(23)02227-1/fulltext
Section Title :
Section Order :
11440
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02227-1&doi=10.1016/j.jval.2023.03.2127